makers of semaglutide Ozempic® (semaglutide) GLP-1 RA for Type 2 Diabetes FDA Sends Warning Letter to

Does semaglutide work faster than tirzepatide

Diabetes Mellitus and the Cardiovascular Metabolic Syndrome: Reducing Cardiovascular and Renal Events

Litigation involving GLP-1 drugs is currently focused on gastrointestinal issues related to the drugs, as well as vision loss in some individuals

For patients with Barrett esophagus or a history of esophageal strictures, close monitoring during semaglutide treatment is essential

You can read a more in-depth explanation and analysis of risk from the Cleveland Clinic , but heres the bottom line: Out of an abundance of caution, anyone with a personal or family history making them more susceptible to C cell thyroid cancer (specifically) is advised not to use a GLP-1 medication